0.83%| Prev Close: | 41.08 |
|---|---|
| Open: | 41.24 |
| Bid: | 40.90 x 200 |
| Ask: | 41.59 x 200 |
| 1y Target Est: | 38.38 |
| Beta: | 0.53 |
| Next Earnings Date: | N/A |
| Day's Range: | 41.04 - 41.68 |
|---|---|
| 52wk Range: | 31.28 - 41.68 |
| Volume: | 1,781,307 |
| Avg Vol (3m): | 1,413,240 |
| Market Cap: | 11.01B |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.12 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- US Launch of Forest's Namenda XRZacks(Mon Jun 17)
- Synergy Pharma rises as analyst starts coverageAP(Mon Jun 17)
- Can Cempra Beat The Superbugs?at Seeking Alpha(Mon Jun 17)
- Forest Reaches New 52-Week High (FRX)at TheStreet(Mon Jun 17)
- Forest Laboratories Inc. (FRX): Today's Featured Health Care Winnerat TheStreet(Fri Jun 14)
- Analysts: BlackBerry Sales Tracking Over Estimates and 3 More Research Notes to Investigateat Wall St. Cheat Sheet(Thu Jun 13)
- Forest Announces U.S. Availability of New Once-Daily NAMENDA XRBusiness Wire(Thu Jun 13)
- Some Dividend Stocks May Still Look Like Winnersat Seeking Alpha(Thu Jun 13)
- Analysts: Tesla Should Hit Its Gen III Targets and 3 More Research Notes to Look Overat Wall St. Cheat Sheet(Wed Jun 12)
- Today's Market: No One Wants To Be The Evil Empireat Seeking Alpha(Wed Jun 12)
- 4 Healthcare Stock Stories For Thursday Inspectionat Wall St. Cheat Sheet(Tue Jun 11)
- Forest Laboratories Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 11:20 AMat Seeking Alpha(Tue Jun 11)
- Forest Adds Icahn Director in Pact to Avoid Proxy Fightat Bloomberg(Tue Jun 11)
- Forest Labs to add Icahn rep to board, avert proxy fightReuters(Tue Jun 11)
- 5 Drugs Stocks Dragging The Industry Downat TheStreet(Tue Jun 11)
Press Releases
- Today’s Research on DCTH, AKRX, ASTX, BMRN, and FRXAccesswire(Fri May 10)
- Almirall and Forest Laboratories Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol Combination in COPDCNW Group(Thu May 2)
- Almirall and Forest Laboratories Announce Positive Results of a Phase III Study for Aclidinium and Formoterol Combination in COPDCNW Group(Tue Apr 16)
Must Read
- Uncertainty over US stimulus drags shares lower in AsiaThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Chrysler expected to formally refuse government's request to recall older Jeeps for fire riskThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Exclusive: Talisman considers sale of Eagle Ford assets - sourcesReuters(1969-12-31T18:59:59GMT-05:00)
- Flush with orders, aerospace industry retools for futureReuters(1969-12-31T18:59:59GMT-05:00)
- McDonald's franchise is sued in Pa. over fee-laden debit card used to pay employeesThe Canadian Press(1969-12-31T18:59:59GMT-05:00)